Company intelligence / Profile preview

Capra Biosciences

Manassas, Virginia, United Statescaprabiosciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Capra Biosciences has developed a patented bioreactor platform that uses metabolically flexible, biofilm-forming marine bacteria to convert organic waste feedstocks into valuable hydrophobic chemicals like retinol used in cosmetics. They are currently demonstrating their ability to rapidly scale production of biologically derived small molecule active pharmaceutical ingredients under a $7.5 million government-backed project agreement. Their technology enables sustainable alternatives to petrochemical-derived products with potential applications in cosmetics, lubricants, and pharmaceuticals.

Therapeutic areas: OtherDermatology
Modalities: Biofilm-based bioreactor microbial fermentation platform producing hydrophobic chemicalsBiologically derived small molecules including retinol and active pharmaceutical ingredients (APIs)
Industry: Non-Drug Biotech

Drug pipeline

1 asset

retinol

Pre-clinical

Indications: Cosmetics

Partnerships

U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response (BioMaP Consortium)Next Rung Technology (AI modeling & bioprocess scaling partner)

Beyond the preview

Go deeper on Capra Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capra Biosciences.

Explore the full profile